Inventor · disambiguated record
Gregory D. Plowman
Also filed as: PLOWMAN GREGORY · PLOWMAN GREGORY D
44 granted patents·81 pending applications·1,399 citations·filing 1987–2018
98Inventor score
Top patents by PatentIndex Score
125 records- 0199US5804396AAssay for agents active in proliferative disordersSUGEN INC·Filed 1994·Granted Sep 8, 1998·480 cites·18 claims
- 0294US8350010B2Anti-alpha5/beta1 antibodyGENENTECH INC·Filed 2011·Granted Jan 8, 2013·25 cites·22 claims
- 0393US6841579B1Diagnosis and treatment of AUR1 and/or AUR2 related disordersSUGEN INC·Filed 2001·Granted Jan 11, 2005·125 cites·7 claims
- 0493US5262177ARecombinant viruses encoding the human melanoma-associated antigenONCOGEN·Filed 1987·Granted Nov 16, 1993·123 cites·34 claims
- 0592US7973138B2AntibodiesGENENTECH INC·Filed 2008·Granted Jul 5, 2011·16 cites·14 claims
- 0692US5811098AAntibodies to HER4, human receptor tyrosine kinaseBRISTOL MYERS SQUIBB CO·Filed 1995·Granted Sep 22, 1998·123 cites·17 claims
- 0789US6207401B1Diagnosis and treatment of AUR-1 and/or AUR-2 related disordersSUGEN INC·Filed 1999·Granted Mar 27, 2001·81 cites·6 claims
- 0887US8962275B2Anti-α5β1 antibodies and uses thereofLIANG WEI-CHING·Filed 2011·Granted Feb 24, 2015·9 cites·9 claims
- 0987US6656716B1Polypeptide fragments of human PAK5 protein kinaseSUGEN INC·Filed 2000·Granted Dec 2, 2003·20 cites·15 claims
- 1086US5962312ADiagnosis and treatment of AUR-1 and/or AUR-2 related disordersSUGEN INC·Filed 1996·Granted Oct 5, 1999·65 cites·20 claims
- 1185US5830995AFanphiregulins: a family of heparin-binding epithelial cell growth factorsBRISTOL MYERS SQUIBB CO·Filed 1992·Granted Nov 3, 1998·65 cites·12 claims
- 1279US7993829B2HPRP4s modifiers of the p53 pathway and methods of useEXELIXIS INC·Filed 2007·Granted Aug 9, 2011·2 cites·10 claims
- 1375US8124740B2Anti- α5 β1 antibodies and uses thereofLIANG WEI-CHING·Filed 2010·Granted Feb 28, 2012·2 cites·5 claims
- 1475US6716575B2Diagnosis and treatment of AUR1 and/or AUR2 related disordersSUGEN INC·Filed 1998·Granted Apr 6, 2004·43 cites·14 claims
- 1575US5141742AVaccines against melanomaONCOGEN·Filed 1991·Granted Aug 25, 1992·48 cites·16 claims
- 1675US5115096AAmphiregulin: a bifunctional growth modulating glycoproteinONCOGEN·Filed 1989·Granted May 19, 1992·39 cites·23 claims
- 1774US6680170B2Polynucleotides encoding STE20-related protein kinases and methods of useSUGEN INC·Filed 1999·Granted Jan 20, 2004·24 cites·18 claims
- 1873US5972676ADiagnosis and treatment of AUR-1 and/or AUR-2 related disordersSUGEN INC·Filed 1997·Granted Oct 26, 1999·26 cites·12 claims
- 1971US8840887B2AntibodiesLIANG WEI-CHING·Filed 2011·Granted Sep 23, 2014·1 cites·20 claims
- 2071US5416192AEpithelins: novel cysteine-rich growth modulating proteinsBRISTOL MYERS SQUIBB CO·Filed 1991·Granted May 16, 1995·29 cites·3 claims
- 2169US2008102070A1SCDs As Modifiers of the p53 Pathway and Methods of UseEXELIXIS INC·Filed 2007·Application pending·0 cites
- 2268US2008166709A1MARKs as Modifiers of the p53 Pathway and Methods of UseEXELIXIS INC·Filed 2007·Application pending·0 cites
- 2367US9375488B2Compounds to fibroblast growth factor receptor-3 (FGFR3) and methods of treatmentIMCLONE LLC·Filed 2014·Granted Jun 28, 2016·2 cites·18 claims
- 2466US2008241131A1SPHKS as modifiers of the p53 pathway and methods of useEXELIXIS INC·Filed 2008·Application pending·0 cites
- 2564US2004234540A1Diagnosis and treatment of ALK-7 related disordersSUGEN INC·Filed 2004·Application pending·0 cites
- 2664US2005026184A1Diagnosis and treatment of alk-7 related disordersSUGEN INC·Filed 2004·Application pending·0 cites
- 2764US2004219139A1Diagnosis and treatment of ALK-7 related disordersSUGEN INC·Filed 2004·Application pending·0 cites
- 2863US2013336960A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 2963US2014017231A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 3063US2014017232A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 3163US2013336959A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 3263US2014193397A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 3363US2014056874A1Method to identify a pateint with an increased likelihood of responding to an anti-cancer therapyGENENTECH INC·Filed 2013·Application pending·0 cites
- 3463US2014056875A1Method to identify a pateint with an increased likelihood of responding to an anti-cancer therapyGENENTECH INC·Filed 2013·Application pending·0 cites
- 3563US2013344059A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyGENENTECH INC·Filed 2013·Application pending·0 cites
- 3663US2014023639A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyGENENTECH INC·Filed 2013·Application pending·0 cites
- 3762US2003165966A1MSRAs as modifiers of the p53 pathway and methods of useFiled 2003·Application pending·0 cites
- 3861US2005054070A1Mammalian protein phosphatasesSUGEN INC·Filed 2003·Application pending·0 cites
- 3961US2004132155A1Mammalian protein phosphatasesSUGEN INC·Filed 2003·Application pending·0 cites
- 4059US2010275275A1HADHs as Modifiers of the p21 Pathway and Methods of UseEXELIXIS INC·Filed 2009·Application pending·0 cites
- 4157US6388063B1Diagnosis and treatment of SAD related disordersSUGEN INC·Filed 1998·Granted May 14, 2002·16 cites·15 claims
- 4257US2004224323A1PAK5 screening methodsSUGEN INC·Filed 2003·Application pending·0 cites
- 4357US2005142625A1Antibodies against PAK5SUGEN INC·Filed 2003·Application pending·0 cites
- 4457US2007072261A1Nucleic acids encoding PAK5 polypeptidesm and methods of use thereofSUGEN INC·Filed 2003·Application pending·0 cites
- 4556US9284376B2AntibodiesLIANG WEI-CHING·Filed 2011·Granted Mar 15, 2016·0 cites·9 claims
- 4656US2008163386A1CRBs as Modifiers of Branching Morphogenesis and Methods of UseEXELIXIS INC·Filed 2007·Application pending·0 cites
- 4755US6818440B2Diagnosis and treatment of alk-7 related disordersSUGEN INC·Filed 1998·Granted Nov 16, 2004·7 cites·19 claims
- 4855US2014004038A1Combinatorial therapyGENENTECH INC·Filed 2012·Application pending·0 cites
- 4955US2003027308A1Novel human protein phosphatases identified from genomic sequencingSUGEN INC·Filed 2001·Application pending·0 cites
- 5054US7119174B2Diagnosis and treatment of AUR1 and/or AUR2 related disordersSUGEN INC·Filed 2003·Granted Oct 10, 2006·0 cites·10 claims
Showing the top 50 of 125 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Gregory D. Plowman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →